Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, et al. Breast Cancer Res Treat 2023 Jun 16. doi: 10.1007/s10549-023-06997.

Read + Share

Amedeo Smart

Independent Medical Education

Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, et al. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat 2023 Jun 16. doi: 10.1007/s10549-023-06997.
PMID: 37326764